Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.26B | $ 1.39B | $ 1.44B | $ 1.79B | $ 1.57B |
Total Assets | $ 9.81B | $ 9.56B | $ 8.12B | $ 8.03B | $ 7.66B |
Total Debt | $ 2.57B | $ 2.34B | $ 2.05B | $ 2.09B | $ 2.21B |
Net Debt | $ 1.31B | $ 943.58M | $ 614.01M | $ 301.53M | $ 639.85M |
Total Liabilities | $ 6.73B | $ 6.59B | $ 5.32B | $ 5.33B | $ 5.06B |
Stockholders Equity | $ 3.01B | $ 2.91B | $ 2.73B | $ 2.65B | $ 2.54B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |